Digoxin Injection, Solution
Product Images NDC 71872-7325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 71872-7325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7325.pdp (7325)

7325.pdp (7325)
Label for Digoxin Injection, USP 500 mcg (0.5 mg) per 2 mL solution, indicated as 250 mcg (0.25 mg) per 2 mL. It is for intravenous or intramuscular injection, supplied as a sterile solution containing digoxin 0.25 mg per mL with propylene glycol, anhydrous ethanol, dibasic sodium phosphate, and citric acid. The product is repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ, and originally manufactured by Sandoz Inc.*
FDA Label Image

Digoxin-chemical-structure (Digoxin 01)

Digoxin-chemical-structure (Digoxin 01)
Chemical structure diagram of Digoxin, showing its steroid nucleus and attached sugar moieties consistent with its known molecular structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.